;in form of free base and salts with pharmaceutically accepted acids, as well as racemate, individual optical isomers or mixture thereof. In formula R1, R2, R3, R4, Y and Z are as described in specification. Compounds of present invention are capable to potentiate (positively modulate) AMPA/KA glutamate receptors and simultaneously to block transmembrane currents induced by activation of NMDA glutamate receptors. Also disclosed are method for production of said compounds, including optical isomers; pharmaceutical composition; method for investigation of glutamatergic system, and method for Alzheimer's disease, treatment; as well as method for extreme retentiveness of memory by administering of effective amount of claimed compounds.;EFFECT: new pharmaceutically active compounds for Alzheimer's disease treatment.;23 cl, 1 tbl, 11 ex"/>
公开/公告号RU2252936C2
专利类型
公开/公告日2005-05-27
原文格式PDF
申请/专利权人
申请/专利号RU20020132699
发明设计人 TKACHENKO S.E. (RU);PROSHIN A.N. (RU);DMITRIEV M.EH. (RU);LERMONTOVA N.N. (RU);GRIGOREV V.V. (RU);BACHURIN S.O. (RU);ZEFIROV N.S. (RU);
申请日2002-12-05
分类号C07C335/12;C07D407/12;C07D409/12;A61K31/155;A61K31/341;A61K31/343;A61K31/36;A61K31/381;A61P25/28;C07D407/12;C07D307/00;C07D307/00;C07D409/12;C07D317/48;C07D333/04;
国家 RU
入库时间 2022-08-21 22:02:04